DrugPatentWatch Database Preview
Uridine triacetate - Generic Drug Details
What are the generic sources for uridine triacetate and what is the scope of uridine triacetate patent protection?
Uridine triacetate
is the generic ingredient in two branded drugs marketed by Wellstat Therap and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are thirty-six drug master file entries for uridine triacetate. One supplier is listed for this compound.
Summary for uridine triacetate
| US Patents: | 2 |
| Tradenames: | 2 |
| Applicants: | 1 |
| NDAs: | 2 |
| Drug Master File Entries: | 36 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 51 |
| Clinical Trials: | 2 |
| Patent Applications: | 61 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | uridine triacetate at DailyMed |
Pharmacology for uridine triacetate
| Ingredient-type | Pyrimidines Analogs/Derivatives |
| Drug Class | Pyrimidine Analog |
Synonyms for uridine triacetate
| (2R,3R,4R,5R)-2-(ACETOXYMETHYL)-5-(2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL)TETRAHYDROFURAN-3,4-DIYL DIACETATE |
| [(2R,3R,4R,5R)-3,4-diacetoxy-5-(2,4-dioxopyrimidin-1-yl)tetrahydrofuran-2-yl]methyl acetate |
| [(2R,3R,4R,5R)-3,4-diacetyloxy-5-(2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methyl acetate |
| 105T388 |
| 2 ,3 ,5 -Triacetyluridine |
| 2',3',5'-Tri-O-acetyluridine |
| 293738-13-3 |
| 2WP61F175M |
| 4105-38-8 |
| AC1L2FGB |
| AK-73070 |
| AKOS015964563 |
| AN-158 |
| ANW-29551 |
| API0001026 |
| AUFUWRKPQLGTGF-FMKGYKFTSA-N |
| AX8007900 |
| CHEBI:90914 |
| CHEMBL2107381 |
| CTK3J5861 |
| D09985 |
| D0OL7F |
| DB09144 |
| EINECS 223-881-5 |
| FT-0081134 |
| J-700012 |
| KSC495Q6D |
| MFCD00023795 |
| MLS006009982 |
| MolPort-005-940-324 |
| NU000494 |
| PN 401 |
| PN401 |
| PubChem14176 |
| RG 2133 |
| SCHEMBL871011 |
| SMR004701034 |
| SY004945 |
| Tri-O-acetyluridine |
| Triacetyluridine |
| UNII-2WP61F175M |
| URI007 |
| Uridine 2',3',5'-triacetate |
| Uridine triacetate (USAN/INN) |
| Uridine triacetate [USAN:INN] |
| Uridine, 2',3',5'-triacetate |
| Vistonuridine |
| Xuriden |
| Xuriden (TN) |
| ZINC3843198 |
US Patents and Regulatory Information for uridine triacetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wellstat Therap | VISTOGARD | uridine triacetate | GRANULE;ORAL | 208159-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Wellstat Therap | VISTOGARD | uridine triacetate | GRANULE;ORAL | 208159-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Wellstat Therap | VISTOGARD | uridine triacetate | GRANULE;ORAL | 208159-001 | Dec 11, 2015 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for uridine triacetate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wellstat Therap | VISTOGARD | uridine triacetate | GRANULE;ORAL | 208159-001 | Dec 11, 2015 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for uridine triacetate
Supplementary Protection Certificates for uridine triacetate
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2017 00036 | Denmark | ➤ Sign Up | PRODUCT NAME: TRIFLURIDINE IN COMBINATION WITH TIPIRACIL OR A PHARMACEUTICALLY ACCEPTABLE SALT OF TIPIRACIL; REG. NO/DATE: EU/1/16/1096 20160427 |
| 0889 | Netherlands | ➤ Sign Up | PRODUCT NAME: TRIFLURIDINE IN COMBINATIE MET TIPIRACILHYDROCHLORIDE; REGISTRATION NO/DATE: EU/1/16/1096 20160427 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: